Metabolic side effects with second generation antipsychotics in antipsychotic-naive adolescents

被引：0
|
作者：
Fraguas, D. [1 ]
Laita, P. [1 ]
Parellada, M. [1 ]
Moreno, D. [1 ]
Cifuentes, A. [1 ]
Ulloa, A. [1 ]
Lozano, R. [1 ]
Arango, C. [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70083-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [1] METABOLIC SIDE EFFECTS IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS AFTER 12 MONTHS OF TREATMENT WITH SECOND-GENERATION ANTIPSYCHOTICS
    Pina, Laura
    Merchan-Naranjo, Jessica
    Garcia-Amador, Margarita
    Arango, Celso
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 29 - 29
  • [2] Metabolic risk after six months of treatment with second-generation antipsychotics in antipsychotic-naive children and adolescents
    Diaz-Caneja, C. M.
    Giraldez-Quiroga, M.
    Merchan-Naranjo, J.
    Pina-Camacho, L.
    Tapia-Casellas, C.
    Rodriguez-Latorre, P.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S71 - S72
  • [3] Age-Dependent Metabolic Effects of Second-Generation Antipsychotics in Second-Generation Antipsychotic-Naive French Canadian Patients
    Roy, Genevieve
    Bedard, Alain
    Desmarais, Paul-Andre
    Jourdain, France
    Allen, Sylvie
    Michaud, Danielle
    Ben Amor, Leila
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 479 - 487
  • [4] Metabolic side effects of second generation antipsychotic agents in antipsychotic-naive patients: One-month prospective evaluation
    Tarricone, Ilaria
    Serretti, Alessandro
    Gozzi, Beatrice Ferrari
    Mandelli, Laura
    Grieco, Daniela
    Mellim, Lorenzo
    Biagim, Stefano
    Berti, Beatrice
    Berardi, Domenico
    [J]. PSYCHIATRY RESEARCH, 2008, 157 (1-3) : 269 - 271
  • [5] Second generation antipsychotic-induced insulin resistance in antipsychotic-naive children and adolescents
    Correll, CU
    Parikh, UH
    Kane, JM
    Malhotra, AK
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 : 16S - 17S
  • [6] Insulin resistance and metabolic risk related to second-generation antipsychotics in antipsychotic-naive pediatric and adult patients
    Diaz-Caneja, C.
    Pina-Camacho, L.
    Corripio, I.
    Gonzalez-Pinto, A.
    Sanjuan, J.
    Arias, B.
    Saiz, P.
    Garcia, A.
    Jimenez-Arriero, M. A.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S430 - S430
  • [7] Weight and metabolic risk associated with second-generation antipsychotics in antipsychotic-naive children and adolescents: A 12 month follow-up study
    Andreu, A.
    Pina-Camacho, L.
    Diaz-Caneja, C.
    Fraguas, D.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S552 - S553
  • [8] Risk for adverse health outcome in antipsychotic-naive adolescents after 12 months of treatment with second-generation antipsychotics
    Pina-Camacho, L.
    Merchan-Naranjo, J.
    Garcia-Amador, M.
    Fraguas, D.
    Tapia, C.
    Moreno, C.
    Llorente, C.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S61 - S62
  • [9] CHANGES IN LEPTIN, ADIPONECTIN AND GHRELIN IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS TAKING SECOND-GENERATION ANTIPSYCHOTICS: COMPARATIVE EFFECTS IN PATIENTS WITH PSYCHOTIC AND NONPSYCHOTIC DISORDERS
    Pina-Camacho, Laura
    Merida, Elena
    Diaz-Caneja, Covadonga M.
    Tapia-Casellas, Cecilia
    Rodriguez-Latorre, Pamela
    Merchan-Naranjo, Jessica
    Fraguas, David
    Moreno, Carmen
    Parellada, Mara
    Arango, Celso
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 136 : S208 - S208
  • [10] Metabolic side effects in children and adolescents treated with second-generation antipsychotics
    Alvarez-Segura, M.
    Fraguas, D.
    Merchan, J.
    Leiva, M.
    Barajas, A.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S563 - S563
12345